Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial

Eur Respir J. 2023 Sep 28;62(3):2300702. doi: 10.1183/13993003.00702-2023. Print 2023 Sep.

¹ Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia diana.mbhf@gmail.com.
² Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden.
³ Cicely Saunders Institute, King's College London, London, UK.
⁴ Faculty of Health, University of Technology Sydney, Ultimo, Australia.
⁵ Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia.

No abstract available

Publication types